ApoA1 Antibody [L13J2]

N. catalogo F5020

Stampa

Descrizione biologica

Specificità ApoA1 Antibody [L13J2] rileva i livelli endogeni della proteina ApoA1 totale.
Contesto L'apolipoproteina A-I (ApoA-I) è la principale proteina strutturale e funzionale delle lipoproteine ad alta densità (HDL), sintetizzata principalmente nel fegato e nell'intestino per mediare il trasporto inverso del colesterolo facilitando l'efflusso di colesterolo dipendente da ABCA1 dai tessuti periferici al fegato per l'escrezione, offrendo così protezione contro l'aterosclerosi e le malattie cardiovascolari. Il polipeptide ApoA-I maturo di 243 amminoacidi comprende 10 ripetizioni in tandem di α-eliche anfipatiche, con residui di prolina che forniscono flessibilità per il legame lipidico; la sua regione N-terminale stabilizza la forma priva di lipidi, il dominio centrale (140-170) attiva la lecitina-colesterolo aciltransferasi (LCAT) per l'esterificazione del colesterolo e la maturazione delle HDL, e il dominio C-terminale (181-243) consente il legame ad alta affinità con i fosfolipidi per la formazione delle HDL nascenti. L'ApoA-I funge da cofattore per LCAT, interagisce con i recettori ABCA1 e SR-BI per promuovere l'efflusso lipidico e mostra forti azioni antinfiammatorie e antiossidanti neutralizzando i lipopolisaccaridi e inibendo l'espressione delle molecole di adesione vascolare. Bassi livelli di ApoA-I sono un predittore di rischio indipendente per la malattia coronarica, mentre le mutazioni di APOA1 causano sindromi da carenza familiare di HDL o amiloidosi ereditaria, portando ad aterosclerosi accelerata o disfunzione d'organo da depositi proteici, con ulteriori collegamenti alla malattia di Alzheimer e al diabete attraverso l'alterata omeostasi lipidica e l'infiammazione cronica.

Informazioni sullutilizzo

Applicazione WB Diluizione
WB
1:1000
Reattività Human
Fonte Mouse Monoclonal Antibody MW 25 kDa
Tampone di conservazione PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Conservazione
(Dalla data di ricevimento)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Riferimenti

  • https://pubmed.ncbi.nlm.nih.gov/10828078/
  • https://pubmed.ncbi.nlm.nih.gov/27382195/

Dati di applicazione

WB

Validato da Selleck

  • F5020-wb
    Lane 1: Human small intestine, Lane 2: Human plasma